- Home
- TWIN vs ALDX Comparison
TWIN vs ALDX Comparison
Compare TWIN & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWIN | ALDX |
|---|---|---|
| Founded | 1918 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.7M | 317.7M |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | TWIN | ALDX |
|---|---|---|
| Price | $14.82 | $4.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.00 | $9.50 |
| AVG Volume (30 Days) | 44.1K | ★ 1.0M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | N/A | ★ 40.43 |
| EPS | ★ 1.53 | N/A |
| Revenue | ★ $340,738,000.00 | N/A |
| Revenue This Year | $10.79 | N/A |
| Revenue Next Year | $8.43 | $123.43 |
| P/E Ratio | $9.84 | ★ N/A |
| Revenue Growth | ★ 15.45 | N/A |
| 52 Week Low | $6.16 | $1.18 |
| 52 Week High | $19.63 | $6.99 |
Technical Indicators
Market Signals| Indicator | TWIN | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 34.88 | 34.77 |
| Support Level | $14.80 | $2.60 |
| Resistance Level | $14.93 | $5.70 |
| Average True Range (ATR) | 0.82 | 0.43 |
| MACD | -0.35 | -0.10 |
| Stochastic Oscillator | 7.24 | 6.36 |
Price Performance
Historical ComparisonAbout TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.